ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
August 2026
Nuclear Technology
July 2026
Fusion Science and Technology
Latest News
Launching into tomorrow: NRIC guides new era of research and deployment
In June 2025, the Department of Energy announced the Reactor Pilot Program, an authorization pathway that allowed reactor developers to partner with the DOE to get first-of-a-kind (FOAK) reactors built and tested. Soon after, the DOE rolled out a complementary Fuel Line Pilot Program, which aimed to fast-track fuel projects. In all, 20 projects were accepted into the new programs.
Eugene Normand
Nuclear Technology | Volume 36 | Number 1 | November 1977 | Pages 65-73
Radiation Environments in Nuclear Reactor Power Plant | Reactor | doi.org/10.13182/NT77-A31959
Articles are hosted by Taylor and Francis Online.
The effect of halogen plateout sources on containment post-loss-of-coolant accident dose rates has been evaluated. The main approach utilized has been to compare the dose rates due to halogen plateout and halogen immersion (or atmospheric) sources, assuming each is comprised of an equal inventory of radioiodines. Based on the parameters chosen, including the use of only the primary 131I photon, 0.36 MeV, for all calculations, the gamma-ray dose rate from the atmospheric component will always dominate over the plateout component for full containment configurations. However, for small chambers within the containment, the atmospheric and plateout dose rates are relatively comparable, so that determining which is greater depends on the location of the dose point.